FDA Approves Morning Sickness Drug Withdrawn from Market Three Decades Ago

by Kathy Jones on  April 9, 2013 at 8:42 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

The US Food and Drug Administration confirmed that it has approved a drug for treating morning sickness that was initially pulled off from the market over 30 years ago following a scare that it could lead to birth defects.
 FDA Approves Morning Sickness Drug Withdrawn from Market Three Decades Ago
FDA Approves Morning Sickness Drug Withdrawn from Market Three Decades Ago

Manufactured by Canadian company Duchesnay, the drug, known as Diclegis, is the only one approved by the FDA to specifically treat morning sickness.

Diclegis is a generic version of the drug Bendectin, which had been withdrawn from the market following claims, which have since been debunked, that it increased the risk of birth defects.

Bendectin was manufactured by Merrell Dow who said that it had pulled the drug not because of any pressure from the FDA or because it was ineffective or posed a danger. Instead the company said that it was forced with withdraw the drug as it did not have the financial capacity to defend itself in courts. Diclegis is also made up of doxylamine succinate and pyroxidine hydrochloride and will be available as a single pill, which will be given only on presenting a prescription.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity Morning Sickness 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive